回盛生物(300871.SZ)发预盈，预计2025年度归母净利润2.35亿元至2.71亿元

Core Viewpoint - The company, Zhi Sheng Bio (300871.SZ), has announced a profit forecast for the year 2025, expecting a net profit attributable to shareholders of between 235 million yuan and 271 million yuan, marking a turnaround from losses to profits [1] Financial Performance - The forecasted net profit after deducting non-recurring gains and losses is estimated to be between 213 million yuan and 249 million yuan [1] - The company is actively expanding both domestic and international markets, leading to revenue growth in both areas [1]